Related Experiment Video
Updated: May 30, 2026

Isolation of Leukocytes from the Human Maternal-fetal Interface
Published on: May 21, 2015
Macrophage migration-inhibitory factor is elevated in pregnant women with gestational diabetes mellitus
Özgür Yilmaz1, Mert Küçük, Levent Kebapçilar
1Department of Obstetrics and Gynecology, Akhisar State Hospital, Akhisar, Manisa, Turkey. ozgur_md@yahoo.com
Objective:
In reports, abnormal macrophage migration-inhibitory factor (MIF) production has been associated with several diseases. Furthermore, despite scarce data, increasing evidence suggest that MIF plays a central role in glucose homeostasis and in the development of type 1 and type 2 diabetes. However, serum MIF levels in gestational diabetes mellitus (GDM) have not yet been investigated. To address this question, we performed a prospective study between a group of pregnant women with GDM and healthy pregnant controls.
Materials And Methods:
GDM group consisted of 43 pregnant women, whereas the control group consisted of 40 healthy pregnant women. In the morning after an overnight fast, venous blood was sampled for the measurement of serum concentrations of insulin and MIF. Serum was separated by centrifugation and immediately stored at -80°C until the assay.
Results:
There was no significant difference between the groups for maternal characteristics. Women with GDM had significantly higher levels of serum insulin (14.37 ± 9.92 µU/ml vs. 8.78 ± 4.35 µU/ml; p = 0.001) and serum MIF concentrations (11.31 ± 4.92 ng/ml vs. 5.31 ± 4.07 ng/ml; p < 0.001) when compared with healthy pregnant control group.
Conclusion:
Our data demonstrated that serum levels of MIF are significantly elevated in patients with GDM. Our findings indicate that MIF might have a role in GDM; however, there is a need for further investigation.
Insights
Gestational diabetes mellitus (GDM) is linked to higher levels of macrophage migration-inhibitory factor (MIF). This study investigated serum MIF in pregnant women with GDM, finding significantly elevated levels. Further research is needed to understand MIF's role in GDM.
Area of Science:
- Endocrinology
- Immunology
- Reproductive Health
Background:
- Macrophage migration-inhibitory factor (MIF) is implicated in various diseases and glucose homeostasis.
- Evidence suggests MIF's role in type 1 and type 2 diabetes, but its involvement in gestational diabetes mellitus (GDM) is unexplored.
Purpose of the Study:
- To investigate serum MIF levels in pregnant women diagnosed with GDM.
- To compare MIF concentrations between GDM patients and healthy pregnant controls.
Main Methods:
- A prospective study was conducted with 43 pregnant women with GDM and 40 healthy pregnant controls.
- Serum insulin and MIF levels were measured from fasting venous blood samples.
- Samples were processed and stored at -80°C prior to analysis.
Main Results:
- No significant differences in maternal characteristics were observed between the GDM and control groups.
- Women with GDM exhibited significantly higher serum insulin levels compared to controls (14.37 ± 9.92 vs. 8.78 ± 4.35 µU/ml, p=0.001).
- Serum MIF concentrations were significantly elevated in the GDM group (11.31 ± 4.92 vs. 5.31 ± 4.07 ng/ml, p<0.001).
Conclusions:
- Serum MIF levels are significantly elevated in women with GDM.
- These findings suggest a potential role for MIF in the pathophysiology of GDM.
- Further research is warranted to elucidate the specific mechanisms and implications of MIF in GDM.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Introduction
Type I Diabetes II: Pathophysiology
Diabetic Retinopathy
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
